← Leaderboards
Helen Keipp Talbot
Vanderbilt University
$7,247,906
Attributed
$8,372,551
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2007–19$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
CDC$6,682,967 · 2
NIH$1,689,584 · 4
By mechanism
U01$6,682,967 · 2
R01$953,844 · 1
K23$501,984 · 1
R03$233,756 · 2
Top collaborators
- Carlos G Grijalva5 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- John V Williams$14,790,794
- Derek J. Williams$5,821,267
- Timothy R Peters$431,736
- Rachael Wolters$368,550
- Lawrence J Marnett$28,791,111
Others in their field
Top investigators on “Respiratory”
- James E. Gern · University Of Wisconsin-Madison$147,090,575
- Richard L Schilsky · University Of Chicago$117,759,216
- Monica M Bertagnolli · Strang Cancer Prevention Center$94,307,968
- Kerry J Kelly · New York City Fire Department$81,924,266
- Mark R Farfel · Hugo W. Moser Res Inst Kennedy Krieger$80,506,780
- John Beigel · Leidos Biomedical Research, Inc.$72,410,171
Research focus
RespiratoryAcuteVirusAge-YearsInfluenzaCessation Of LifeMorbidity - Disease RateVaccine EffectivenessHospitalizationAdultDetectionInfluenza Virus VaccinePneumoniaInfluenza VaccinationElderlyDiagnosisDiagnostic ProcedureAntigensVaccinationViralBaseAgedSurveillance ProgramMortality Vital Statistics
Grant awards (25)
Determining Influenza Vaccine Effectiveness (DIVE)$830,000
U01 · FY2019 · IP · contact PI
Determining Influenza Vaccine Effectiveness (DIVE)$533,970
U01 · FY2019 · IP · contact PI
Household Transmission of Influenza Viruses in the Community-COVID 19 Supplement$500,000
U01 · FY2019 · IP
Household Transmission of Influenza Viruses in the Community$500,000
U01 · FY2019 · IP
Household Transmission of Influenza Viruses in the Community$250,000
U01 · FY2019 · IP
Determining Influenza Vaccine Effectiveness (DIVE)$899,935
U01 · FY2018 · IP · contact PI
Determining Influenza Vaccine Effectiveness (DIVE)$500,000
U01 · FY2018 · IP · contact PI
Household Transmission of Influenza Viruses in the Community$499,639
U01 · FY2018 · IP
Determining Influenza Vaccine Effectiveness (DIVE)$136,643
U01 · FY2018 · IP · contact PI
Determining Influenza Vaccine Effectiveness (DIVE)$649,796
U01 · FY2017 · IP · contact PI
Household Transmission of Influenza Viruses in the Community$499,651
U01 · FY2017 · IP
Determining Influenza Vaccine Effectiveness (DIVE)$552,431
U01 · FY2016 · IP · contact PI
Hospital Admissions & Emergency Room Visits in Adults Associated with Influenza C$61,087
R03 · FY2016 · AI · contact PI
Determining Influenza Vaccine Effectiveness (DIVE)$30,902
U01 · FY2016 · IP · contact PI
Hospital Admissions & Emergency Room Visits in Adults Associated with Influenza C$17,524
R03 · FY2016 · AI · contact PI
Effectiveness of the Influenza Vaccine in the Aging Population$312,194
R01 · FY2015 · AG · contact PI
Determining Influenza Vaccine Effectiveness (DIVE)$300,000
U01 · FY2015 · IP · contact PI
Hospital Admissions & Emergency Room Visits in Adults Associated with Influenza C$78,500
R03 · FY2015 · AI · contact PI
Effectiveness of the Influenza Vaccine in the Aging Population$321,850
R01 · FY2014 · AG · contact PI
Effectiveness of the Influenza Vaccine in the Aging Population$319,800
R01 · FY2013 · AG · contact PI
Adult flu hospitalizations: evaulating diagnostic methods & vaccine effectiveness$125,496
K23 · FY2011 · AI · contact PI
Adult flu hospitalizations: evaulating diagnostic methods & vaccine effectiveness$125,496
K23 · FY2010 · AI · contact PI
Adult flu hospitalizations: evaulating diagnostic methods & vaccine effectiveness$125,496
K23 · FY2009 · AI · contact PI
Adult flu hospitalizations: evaulating diagnostic methods & vaccine effectiveness$125,496
K23 · FY2008 · AI · contact PI
Epidemiology and Clinical Features of Human Coronavirus$76,645
R03 · FY2007 · AI · contact PI